P53 germline mutations in childhood cancers and cancer risk for carrier individuals

British Journal of Cancer

Volumn 82, Issue 12, 2000, Pages 1932-1937

  Chompret, A ^a   Brugieres L ^a   Ronsin, M ^a   Gardes, M ^a   Dessarps Freichey, F ^a   Abel, A ^a   Hua, D ^a   Ligot, L ^a   Dondon, M G ^a   Bressac De Paillerets, B ^a   Frebourg T ^b   Lemerle, J ^a   Bonaiti Pellie C ^a   Feunteun, J ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer risk; Germline; P53 mutation

Indexed keywords

PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL MODEL;

ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INFANT; MALE; NEOPLASMS; RISK; SEX FACTORS;

EID: 0034071085     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibáñez-Koref MF (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304
2. Brugières L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaïti-Pellié C, Lemerle J and Feunteun J (1993) Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res 53: 452-455
3. Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25: 101-124
4. Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR and Blake PR (1993) Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumors: molecular and immunohistochemical findings. Oncogene 8: 1269-1279
5. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, Poplack DG, Costin D and Minna JD (1993) A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8: 1203-1210
6. Flaman J-M, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino A-P, Limacher J-M, Bron L, Benhattar J, Tada M, Van Meir EG, Estreicher A and Iggo RD (1995) A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 92: 396.3-3967
7. Frebourg T, Barbier N, Van Y, Garber JE, Dreyfus M, Fraumeni J, Jr, Li FP and Friend SH (1995) Germline p53 mutations in 15 families with Li-Fraumeni syndrome. Am J Hum Genet 56: 608-615
8. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF, Jr and Li FP (1991) Follow-up study of 24 families with Li-Fraumeni syndrome. Cancer Res 51: 6094-6097
9. Gutiérrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS and Magrath IT (1994) A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors. Hum Mol Genet 3: 2247-2248
10. Ishioka C, Frebourg T, Yan Y-X, Vidal M, Friend SH, Schmidt S and Iggo R (1993) Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 5: 124-129
11. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE and Look TA (1994) Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. Oncogene 9: 97-102
12. Knudson AG Jr (1971) Mutation and cancer. Statistical analysis of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823
13. Kony SJ, De Vathaire F, Chompret A, Shamsaldim A, Grimaud E, Raquin M-A, Oberlin O, Brugières L, Feunteun J, Eschwège F, Chavaudra J, Lemerle J and Bonaiti-Pellié C (1997) Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet 350: 91-95
14. Le Bihan C and Bonaïti-Pellié C (1994) A method for estimating cancer risk in p53 mutation carriers. Cancer Detect Prev 18: 171-178
15. Le Bihan C, Moutou C, Brugières L, Feunteun J and Bonaïti-Pellié C (1995) Arcad: a method for estimating age-dependent disease risk associated with mutation carrier status from family data. Genet Epidemiol 12: 13-25
16. Li FP, Fraumeni JF, Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW (1988) A cancer family syndrome in 24 kindreds. Cancer Res 48: 5358-5362
17. Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM and Camplejohn RS (1997) Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family. Oncogene 14: 1869-1874
18. Lustbader ED, Williams WR, Bondy ML, Strom S and Strong LC (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet 51: 344-356
19. Malkin D (1994) p53 and the Li-Fraumeni syndrome. Biochim Biophys Acta Rev Cancer 1198: 197-213
20. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Borresen A-L, Li FP, Garber J and Strong LC (1992) Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326: 1309-1315
21. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen A-L, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D and Gebhardt MC (1994) Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12: 925-930
22. Scott RJ, Krummenacher F, Mary J-L, Weber W, Spycher M and Müller H (1993) Inheritable p53 mutation in a patient with multiple cancer and its significance for genetic counselling. Schweiz Med Wochenschr 123: 1287-1292
23. Speiser P, Gharehbaghi-Schnell E, Eder S, Haid A, Kovarik J, Nenutil R, Sauter G, Schneeberger CH, Vojtesek B, Wiltschke CH and Zeillinger R (1996) A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies. Br J Cancer 74: 269-273
24. Strong L, Williams W and Tainsky MA (1992) The Li-Fraumeni syndrome: from clinical epidemiology to molecular genetics. Am J Epidemiol 135: 190-199
25. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR and Yandell DW (1992) Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med 326: 1301-1308
26. Varley JM, McGown G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell ELD, Boyle J, Birch JM and Evans DGR (1996) A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome. Oncogene 12: 2437-2442
27. Varley JM, Evans DGR and Birch JM (1997b) Li-Fraumeni syndrome: a molecular and clinical review. Br J Cancer 76: 1-14
28. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997a) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57: 3245-3252
29. Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G, Evans DG, Harris M, Kelsey AM and Birch JM (1999) Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 65: 995-1006